Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease
Clinical trial NCT02539368 · COMPLETED
Trial details
- NCT number
- NCT02539368
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-22
- Primary completion
- 2018-10-31
- Enrollment
- 2565
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.